PHI with Cranial nerve thrombosis
How does this condition affect your private health insurance?
Cranial nerve thrombosis, or "Thrombose der Hirnnerven," is a rare and severe condition characterized by the formation of a blood clot within the blood vessels supplying one or more of the twelve cranial nerves. This obstruction disrupts blood flow, leading to nerve dysfunction. Symptoms vary greatly depending on the affected nerve, and can include acute vision loss, facial weakness, hearing impairment, difficulty swallowing, or problems with eye movement. Underlying causes are diverse, often involving hypercoagulable states, vasculitis, infections, or trauma. Diagnosis relies on advanced imaging like MRI or CT angiography. Treatment primarily involves anticoagulation to dissolve the clot and prevent recurrence, along with managing the underlying etiology. Prognosis is variable; some patients achieve good recovery, while others may experience lasting neurological deficits.
PKV Risk Assessment
However, some specialized PHI providers may insure you with a surcharge of up to 30%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Hours to days (acute onset)
Duration of Illness (Lifetime)
One-time event with potential for chronic neurological deficits
Cost of Treatment (Initial)
High (e.g., tens of thousands of USD/EUR)
Cost of Treatment (Lifetime)
Variable, moderate to very high if chronic deficits persist, including rehabilitation and long-term medication
Mortality Rate
Moderate (e.g., 5-20%)
Risk of Secondary Damages
High (e.g., 50-80%) for lasting neurological deficits (e.g., paralysis, vision loss)
Probability of Full Recovery
Moderate to low (e.g., 20-40%)
Underlying Disease Risk
High (e.g., 60-90%) for systemic conditions (e.g., hypercoagulable states, autoimmune diseases)